Science Explorer Back to mapMap
Discussion
Researcher · Evangelisches Krankenhaus Hamm · Germany

L. Balleisen

L. Balleisen publishes mostly in Hematology, Genetics and Molecular Biology, on topics such as Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments and Chronic Lymphocytic Leukemia Research.

OpenAlex
World rank
#5,306,851
of 7,710,434 ranked researchers
Rank in Germany
#274,397
of 364,343
Works
20
Citations
156
Citations per work
7.8
h-index
5
i10-index 3Top 89% in Hematology
L. Balleisen

What does L. Balleisen research?

L. Balleisen's work is mostly in Medicine (63%), Biochemistry, Genetics and Molecular Biology (8%).

Health Sciences: 13 works · 63.2% of their workMedicine: 13 works · 63.2% of their workHematology: 7 works · 36.7% of their workGenetics: 2 works · 8.2% of their workCardiology and Cardiovascular Medicine: 1 works · 6.1% of their workInternal Medicine: 1 works · 6.1% of their workSurgery: 1 works · 6.1% of their workEverything else: 6 works · 28.6% of their workLife Sciences: 2 works · 8.2% of their workBiochemistry, Genetics and Molecular Biology: 2 works · 8.2% of their workMolecular Biology: 2 works · 8.2% of their workTHEIR WORKL. Balleisen20works
Life Sciences8%Health Sciences63%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1363.2%
  2. Everything else628.6%
    1. Biochemistry, Genetics and Molecular Biology28.2%
  1. 1Hematology37% of their works
  2. 2Genetics8% of their works
  3. 3Molecular Biology8% of their works
  4. 4Surgery6% of their works
  5. 5Cardiology and Cardiovascular Medicine6% of their works
  6. 6Internal Medicine6% of their works

Research topics

Which keywords describe L. Balleisen's research?

The keywords of their largest research topics: Prognostic Factors, Acute Myeloid Leukemia, AML, BCR-ABL, Imatinib, Minimal Residual Disease, Antithrombotic Therapy and Chronic Lymphocytic Leukemia.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Prognostic Factors123 topics
  2. AML71 topic
  3. Acute Myeloid Leukemia71 topic
  4. BCR-ABL61 topic
  5. Imatinib61 topic
  6. Minimal Residual Disease42 topics
  7. Antithrombotic Therapy31 topic
  8. Chronic Lymphocytic Leukemia31 topic
  9. Genomic Aberrations31 topic
  10. Venous Thromboembolism31 topic
  11. Acute Lymphoblastic Leukemia21 topic
  12. Childhood Cancer21 topic
  13. DNA21 topic
  14. Diagnosis Criteria21 topic
  15. Fusion Genes21 topic
  16. Hypereosinophilic Syndrome21 topic
  17. International Myeloma Working Group21 topic
  18. Topoisomerases21 topic

Where does L. Balleisen work?

L. Balleisen's main affiliation in the publication record is Evangelisches Krankenhaus Hamm, Germany.

How many publications and citations does L. Balleisen have?

OpenAlex counts 20 works and 156 citations for L. Balleisen, an h-index of 5, ranking #5,306,851 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about L. Balleisen. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.